A Review On Step-by-Step Analytical Method Validation
A Review On Step-by-Step Analytical Method Validation
Vignan Pharmacy College, Vadlamudi, Guntur (Dist.) - 522213, Andhra Pradesh State, India.
Abstract: When analytical method is utilized to generate results about the characteristics of drug related
samples it is essential that the results are trustworthy. They may be utilized as the basis for decisions relating to
administering the drug to patients. Analytical method validation required during drug development and
manufacturing and these analytical methods are fit for their intended purpose. To comply with the requirements of
GMP pharmaceutical industries should have an overall validation policy which documents how validation will be
performed. The purpose of this validation is to show that processes involved in the development and manufacture
of drug, production and analytical testing can be performed in an effective and reproducible manner. This review
article provides guidance on how to perform validation characteristics for the analytical method which are
utilized in pharmaceutical analysis.
Keywords: Analytical method validation, Pharmaceutical analysis, Specificity, Precision, Accuracy.
I.
INTRODUCTION
It may be defined that Analytical chemistry is the study of separation, quantification and chemical
components identification of natural and artificial materials constituted with one or more compounds or
elements. Analytical chemistry is separated into two main categories, qualitative analysis that is to say the
identification with regard to the chemical components exist in the sample, where as quantitative
analysis estimates the amount of certain element or compound in the substance i.e., sample.
Pharmaceutical analysis [1-3] plays a very outstanding role in the examination of pharmaceutical
formulations and bulk drugs regarding the quality control and assurance. Rapid increase in pharmaceutical
industries [4] and production of drug in and around the world bring forward a rise in inevitable demand to seek
novel and systematic analytical techniques in the pharmaceutical industries. As a consequence, analytical
method development has become the basic activity of analysis.
Development in scientific and concrete analytical methods has been resulted from the advancements of
analytical instruments. The improvements of the analytical method development and analytical instruments have
reduced the time and cost of analysis [5] and enhanced precision and accuracy. Techniques pertaining to analysis
are developed and validated for active pharmaceutical ingredients, excipients, related substances, drug products,
degradation products and, residual solvents, etc. Resulting which become an integral part of the required
necessities for regulatory organization[6].
Analytical method development finally results in official test methods[7]. Consequently quality control
laboratories used these methods to check the efficacy, identity, purity, safety as well as performance of products
of the drug. Regulatory authorities give utmost importance on analytical methods in manufacturing. Drug
approval by regulatory authorities requires the applicant to prove control of the entire process of drug
development by using validated analytical methods[8].
The numerous novel drugs are being introduced and are constantly growing day by day. Therefore it is
absolutely imperative to evolve novel methods and introduced them for controlling their quality. Modern
pharmaceutical analysis needs the following requirements.
1. The analysis should take a minimal time and should be economical.
2. The accuracy of the analysis must accept the guidelines of Pharmacopoeia.
3. The chosen method should be precise and selective.
b)
When there is no decorous analytical process for the existing drug in the literature due to patent
regulations.
c)
When there are no analytical methods for the formulation of the drug due to the interference caused
by the formulation excipients.
d)
Analytical methods for the quantitation of the analyte in biological fluids are found to be unavailable.
e)
The existing analytical procedures may need costly reagents and solvents. It may also involve
burdensome extraction and separation procedures.
All known important information about the analyte and its structure that is to say physico-chemical
properties like solubility, optical isomerism etc., is collected.
b) The standard analyte (100 % purity) is obtained. Necessary arrangement is to be made for the perfect
storage (refrigerator, desiccators, and freezer).
c) In the sample matrix when multiple components are to be analyzed, the number of components is noted
duly presenting the data and the accessibility of standards is estimated.
d) Methods like spectroscopic, HPLC, GC, MS etc., are considered when matched with the sample
stability.
a)
Duly utilizing the information available from the literature, methodology is evolved since the
methods are changed wherever required. Occasionally it is imperative to get additional
instrumentation to develop, modify or reproduce and validate existing procedures for analytes and
samples.
b)
If there are no past suitable methods available to analyze the analyte to be examined.
3.8. Optimization
While performing optimization, one parameter is changed at a time and a set of conditions are isolated,
before utilizing trial and error approach. The said work need to be accomplished basing on a systematic
methodical plan duly observing all steps and documented with regard to dead ends.
System suitability
1.
Specificity
2.
Linearity
3.
Precision
4.
Accuracy
5.
LOD
7.
LOQ
8.
Robustness
Resolution (Rs).
10
=
=
=
=
(1)
L = length of column.
N = plate number.
The above said capacity factor sometimes is called as a retention factor which has no dimension and
independent from flow rate of mobile phase as well as column dimensions which is the measure of extent of
retention relating to an analyte relative to an un-retained peak. Where tR implies retention time of the sample
peak and retention time of an un-retained peak is tM.
k' = 0 means no compound is left in the column. Generally the value of k' is > 2.
11
Resolution (Rs)
Resolution is the capability of the column to separate 2 drugs in 2 individual peaks or chromatographic
zones and it is improved by enhancing column length, reduction of particle size and rising temperature, altering
the eluent or stationary phase. It can be told in terms of ratio of separation of the apex of two peaks by the
tangential width average of the peaks. By using the following formula resolution is calculated.
(4)
(5)
12
(6)
Parameter name
Acceptance criteria
> 2000
<1
>1
Resolution (Rs)
> 1.5
<2
<2
4.2. Specificity
One of the significant features of HPLC is its ability to generate signals free from interference.
Specificity refers to the ability of the analytical method to differentiate and quantify the analyte in complex
mixtures. An investigation of specificity is to be conducted during the determination of impurities and validation
of identification tests.
An ICH guideline defines specificity as ability to assess unequivocally the analyte in the presence of
other compounds that may be likely to be present. Typically these might be impurities, degradants, matrix, etc.
The definition has the following implications:
Identification test: Identification tests should be able to differentiate compounds of closely related
structure which are expected to be present i.e., to assure identity of an analyte.
Purity test: To ensure that the analytical procedure performed allows an accurate statement of
content of the impurity of an analyte i.e. related substances, residual solvents content, heavy metals,
etc.
Assay: To arrive at an accurate result, this permits a correct report on the potency or content of analyte
in a sample.
13
4.4. Precision
The precision of an analytical procedure represents the nearness of agreement between a series of
measurements got from multiple sampling of the same homogenous sample under the similar analytical
conditions and it is divided into 3 categories.
Repeatability: precision under same operating conditions, same analyst over a short period of time.
Intermediate precision: method is tested on multiple days, instruments, analysts etc.
Reproducibility: inter-laboratory studies.
The ICH guidelines suggest that repeatability should be conformed duly utilizing at least 9
determinations with specified range for the procedure (e.g., three concentrations / three replicates each) or a
minimum of 6 determinations at 100 % of the test concentration.
4.5. Accuracy
The accuracy of a measurement is defined as the closeness of the measured value to the true value. In
a method with high accuracy, a sample (whose true value is known) is analyzed and the measured value is
identical to the true value. Typically, accuracy is represented and determined by recovery studies. There are
three ways to determine accuracy:
1.
2.
3.
Visual evaluation.
Signal-to-noise ratio.
(7)
14
Visual evaluation.
Signal-to-noise ratio.
Standard deviation of the response.
Standard deviation of the slope of linearity plot.
(8)
4.8. Robustness
Robustness is defined by the measure of the capability of an analytical method to stay unchanged by
small deliberate changes in method parameters. The variable method parameters in HPLC technique may
involves flow rate, column temperature, sample temperature, pH and mobile phase composition.
5.1. Precision
Precision may be defined as the concordance of a series of measurements (n) of the same quantity.
Precision expresses the reproducibility of a measurement. One of the most common statistical terms employed
for precision is the sample standard deviation which is shown in the following equation.
(9)
The square of standard deviation is called Variance (S2). RSD or % RSD is the absolute value of the
CV (Coefficient of Variation) and it is often stated as a % which is used to juxtapose the uncertainty among
different measurements of varying total magnitude.
5.2. Accuracy[26]
Accuracy normally refers to the difference between the mean x of the set of results and the true or
most probable value for the quantity measured. As stated by IUPAC, accuracy relates to the difference between
result (or) mean and the true value. For analytical methods, there are two feasible ways of determining the
accuracy: absolute method and comparative method.
Absolute method
The test of the accuracy of the method under consideration is carried out by taking amounts of the
constituents and proceeds as said by specified instructions to perform the test for accuracy of the method. The
difference between the means of an adequate number of results and amount of constituent in fact present,
usually expressed as parts per hundred (%) which is termed as % error.
15
Comparative method
In the analysis of pharmaceutical formulations (or solid synthetic samples of desired composition), the
content of the constituent to be sought has been determined by one or more accurate analysis methods. Basically
if several distant (dissimilar) methods of analysis for a given constituent are available, e.g. gravimetric,
titrimetric, spectrophotometric, or chromatographic, the agreement between at least two methods of essentially
different character can generally be accepted as indication of the absence of an appreciable systematic error in
either method.
Recovery experiments
A known amount of the constituent being estimated is added to the sample, which is analyzed for the
total amount of constituent present. The difference between the analytical results for samples with and without
the added constituent gives the recovery of the amount of the added constituent. If the recovery is satisfactory,
our confidence in the accuracy of the procedure is improved.
Student t-test
Student t-test is used to compare the means of two related (paired) samples analyzed by reference and
test methods. It gives answer to the correctness of the null hypothesis with a certain confidence such as 95 % or
99 %. If the number of pairs (n) is less than 30, the condition normality of x or at least the normality of the
difference (di) is required. If this is the case the quantity has a student t-distribution with (n -1) degrees of
freedom.
di
(10)
sd / n
Where di = xR (Reference method) xT. (Test method) and sd is the standard deviation.
F-test
By the F-test we can test the significance of the difference in variances of reference and test methods.
Let us suppose that one carried out n1 replicate measurements by test methods and n2 replicate measurements by
using reference method. If the null hypothesis is true then the estimates S T2 (variance of the test method) and SR2
(variance of reference method) do not differ very much and their ratio should not differ much from unity. In
fact, one uses the ratio of variances.
F = ST2 / SR2
(11)
It is conventional to calculate the F - ratio by dividing the larger variance by the smaller variance in
order to attain a value equal or larger than unity. If the calculated F - value is smaller than F - value from the Ftable, one can conclude that the procedures are not significantly different in precision at a given confidence
level.
5.4. Calibration
A very essential part of all analytical procedures is the calibration and standardization process.
Calibration determines the relationship between the analytical response (Absorbance, peak area, peak height
etc.,) and the analyte concentration. Generally this is accomplished by the use of chemical standards. A good
precision and accuracy can only be obtained when an excellent calibration procedure is used. In pharmaceutical
analysis the following calibration procedures are normally employed.
16
Yi
(12)
The signal yi is composed of deterministic component predicted by linear model and a random
component ei. One must now find the estimates of a and b of the two values and . This can be done by
calculating values a and b for which ei2 is minimal. The component ei represent the differences between the
observed yi values and the predicted yi values by the model. The ei are called the residuals, a and b are the
intercept and slope respectively.
n
n xi yi
i 1
xi yi
i 1
i 1
n x xi
i 1
i 1
n
2
i
17
(13)
i 1
i 1
i 1
yi xi2 xi xi yi
i 1
2
n xi2 xi
i 1
i 1
n
( y
Se
i 1
(14)
yi ) 2 /( n 2)
yi
and yi , are the observed and predicted values, respectively. Standard deviations on slopes (S b)
and intercepts (Sa) are quoted less frequently, even though they are used to evaluate proportional differences
between or among methods as well as to compute the independent variables such as concentration etc. It is
important to understand how uncertainties in the slope are influenced by the controllable properties of the data
set such as the number and range of data points and also how properties of data sets can be designed to optimize
the confidence in such data.
Sb
( yi yi ) 2
i 1
(n 2)
1
n
(15)
( xi xi ) 2
i 1
Where
Here
xi
Sa
is
( yi yi ) 2
i 1
(n 2)
1
n
(x x )
i 1
x
i 1
2
i
(16)
the
arithmetic mean of
xi
values
18
(
x
x
)(
y
y
)
i
i
/( n 1)
r
n
2
2
2
(
x
x
)
(
y
y
)
i
i
/( n 1)
(17)
VI. CONCLUSION
This article provides an idea how to perform validation process to prove that the method is apt for its
intended purpose and to assure the capabilities of the test method. The definitions of method validation
parameters are well explained. Although the requirements of validation have been clearly documented by
regulatory authorities, the approach to validation is varied and opened to interpretation, and validation
requirements differ during the development process of pharmaceuticals. Validation is an important procedure in
the pharmaceutical industry and it is utilized to ensure that quality is built in to the processes supporting drug
development and manufacture.
REFERENCES
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
G. David Watson, Pharmaceutical Analysis (3rd Ed., Churchill Livingstone, London: Harcourt Publishers Limited, Essex CM 20
2JE, 2012).
A.H. Beckett, and J.B. Stenlake, Practical Pharmaceutical Chemistry (4th Ed., Vol. I & II. CBS Publishers and Distributors, New
Delhi: 2007).
T. Higuchi, and Brochman-Hansen, Pharmaceutical Analysis, (3rd edition, CBS Publishers and Distributors pvt. Ltd., New
Delhi:1997).
G. Oliver, R. Gerrit, and VZ. Maxmilian, Leading Pharmaceutical Innovation, Trends and drivers for Growth in the
pharmaceutical industry, (2nd Ed., Springer, 2008)12-15.
Br. Jay, J. Kelvin, and B. Pierre, Understanding and Implementing Efficient Analytical Methods Development and Validation,
2003.
R.M. Christopher, and W.R. Thomas, Quality Systems approach to Pharmaceutical cGMP Development and validation of
Analytical Methods, (1st Ed., 2005) 147-152.
R. Lloyd Snyder, J. Joseph Kirkland and L. Joseph Glajah, Practical HPLC method development (2nd Ed., 1997) 179-184.
B.K. Sharma, Instrumental method of chemical analysis (29th Ed., Meerut, Chromatography, HPLC, Goel Publishing House,
2013) 286-385.
H.H. Willard, L.L. Merrit, J.A. Jr. Dean, and F.A. Jr. Settle, Instrumental Methods of Analysis (CBS Publishers, New Delhi:
1986).
R.A. Day, and A.L, Underwood, Quantitative Analyses, (5th Ed., Prentice Hall, New Delhi: 1986).
Macek and Karel, Pharmaceutical Applications of Thin Layer and Paper Chromatography, 62(6) 1972,1032.
G. Ramana Rao, S.S.N. Murthy, and P. Khadgapathi, Gas Chromatography to Pharmaceutical Analysis, Eastern Pharmacist,
30(353), 1987, 35.
G. Ramana Rao, S.S.N. Murthy, and P. Khadgapathi, High Performance Liquid Chromatography and its Role in Pharmaceutical
Analysis, Eastern Pharmacist, 29(346), 1986,53.
C.S.P. Sastry, T.N.V. Prasad, and E.V. Rao, Recent applications of High Performance Liquid chromatography in Pharmaceutical
analysis, Indian J. Pharm. Education, 21 (37),1987.
Ravisankar P, Gowthami S, and Devala Rao G, A review on analytical method development, Indian journal of research in
pharmacy and biotechnology, 2(3), 2014, 1183-1195.
Ravisankar P, Rajyalakshmi G, Devadasu Ch, and Devala Rao G, Instant tips for right and effective approach to solve HPLC
trouble shooting, Journal of chemical and pharmaceutical sciences. 7(3), 2014, 259-274.
Jay Breaux, Kevin Jones, and Pierre Boulas, Development services analytical method development and validation
Pharmaceutical technology, 27(1), 2003, 6-13.
E. Michael Swartz, and Iras Krull, Analytical method development and validation, CRC press, Marcel dekker, Inc., Madison
Avenue, New York: 1997.
K. Yuri, and LB. Rosario, HPLC for pharmaceutical scientists, (John Wiley and Sons, Inc., Hoboken, New Jersey, 2007) 92-98.
G. P. Carr, and J. C. Wahlichs. A practical approach to method validation in pharmaceutical analysis, J. Pharm, Biomed.
Anal,8,1990,613-618.
United States Pharmacopoeia,24, National Formulary 19, section <1225> Validation of compendial methods. US
Pharmacopoeial convention, Rockville, Validation of analytical procedures text and methodology Q2 (R1), November, 2000:
2005.
International conference on harmonization (ICH) of technical requirements for registration of pharmaceuticals for human use,
Validation of analytical procedures: Text methodology, (Q2 (R1) Geneva, 2005) 6-13.
Draft guidance analytical procedures and method validation, US food and drug administration, Centre for drugs and biologics,
Department of Health and Human Services. http://www.fda.gov/cder/guidance/2396 dft.htm#111, 2000.
Orr J.D, Krull I.S and Swartz M.E, Validation of impurity methods Part II, (LC North Am; 21, 2003) 1146-1152.
ICH Q2 (R1), Validation of analytical procedures (definitions and terminology); 2005; pp. 9-10.
D.L. Massart, B.G.M. Vandeginste, S.N. Deming, Y. Michotte and L. Kaufman, Chemometrics: A Text Book, Elsevier,
Amsterdam: 1988.
M.M. Kiser and J.W. Dolan, Selecting the best curve fit LC-GC (Europe: 2004)138-143.
R.E. Moore, Interval analysis (Englewood Cliffs, NJ: Prentice-Hall, 1966).
19